Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Qualman

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology groupPoul H B Sorensen, James C Lynch, Stephen J Qualman, et al.
Pediatric Blood & Cancer|February 13, 2009
Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastomaEri Taniguchi, Min Jung Cho, Benjamin R Arenkiel, et al.
The American Journal of Pathology|January 17, 2009
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology GroupElai Davicioni, Michael J Anderson, Friedrich Graf Finckenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study GroupK Scott Baker, James R Anderson, Thom E Lobe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IVJohn C Breneman, Elizabeth Lyden, Alberto S Pappo, et al.
Medical and Pediatric Oncology|February 9, 2002
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997Richard Beverly Raney, Jane Meza, James R Anderson, et al.
Cancer Research|April 3, 2009
Credentialing a preclinical mouse model of alveolar rhabdomyosarcomaKoichi Nishijo, Qing-Rong Chen, Lei Zhang, et al.
The Journal of Clinical Investigation|October 8, 2009
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted modelsJames G Taylor, Adam T Cheuk, Patricia S Tsang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology groupPoul H B Sorensen, James C Lynch, Stephen J Qualman, et al.
Pediatric Blood & Cancer|February 13, 2009
Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastomaEri Taniguchi, Min Jung Cho, Benjamin R Arenkiel, et al.
The American Journal of Pathology|January 17, 2009
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology GroupElai Davicioni, Michael J Anderson, Friedrich Graf Finckenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study GroupK Scott Baker, James R Anderson, Thom E Lobe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IVJohn C Breneman, Elizabeth Lyden, Alberto S Pappo, et al.
Medical and Pediatric Oncology|February 9, 2002
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997Richard Beverly Raney, Jane Meza, James R Anderson, et al.
Cancer Research|April 3, 2009
Credentialing a preclinical mouse model of alveolar rhabdomyosarcomaKoichi Nishijo, Qing-Rong Chen, Lei Zhang, et al.
The Journal of Clinical Investigation|October 8, 2009
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted modelsJames G Taylor, Adam T Cheuk, Patricia S Tsang, et al.
Pageof 4